CLINICAL AND PARACLINICAL CHARACTERISTICS OF PATIENTS WITH INFLAMMATORY BOWEL DISEASE ASSOCIATED WITH INFECTION

Thanh Lâm Lương, Ngọc Ánh Trần, Trường Sơn Nguyễn, Gia Mạnh Ngô

Main Article Content

Abstract

Inflammatory Bowel Disease (IBD) is a chronic inflammatory condition of the gastrointestinal tract, with a rising prevalence in developing countries. Infection represents a major determinant of increased hospitalization and suboptimal therapeutic outcomes in IBD. We conducted a cross-sectional study involving 62 infected and 169 non-infected patients at Hanoi Medical University Hospital and Bach Mai Hospital. The cohort was predominantly male (55%), with 10,4% aged over 65 years, and a mean hospital stay of 14,5 ± 8,2 days. The most common gastrointestinal infection in both Crohn’s disease and ulcerative colitis was observed at rates of 22,5% and 26,1%, respectively, with the predominant clinical manifestations being fever (100%) and abdominal pain (71%). Infection was most frequent in severe disease (33,3%) and strongly associated with TNF-α inhibitors or combination therapy. Infected patients showed elevated leukocyte count, ESR, hs-CRP, and PCT compared with non-infected cases.

Article Details

References

Ananthakrishnan AN, McGinley EL. Infection-related hospitalizations are associated with increased mortality in patients with inflammatory bowel diseases. J Crohns Colitis. 2013;7(2):107-112. doi:10.1016/j.crohns.2012.02.015
2. Irving PM, de Lusignan S, Tang D, Nijher M, Barrett K. Risk of common infections in people with inflammatory bowel disease in primary care: a population-based cohort study. BMJ Open Gastroenterol. 2021;8(1):e000573. doi:10.1136/ bmjgast-2020-000573
3. Trần Ngọc Ánh. Cấp Cứu Nội Tiêu Hóa.; 2021. https://thuvien.hmu.edu.vn/pages/cms/FullBookReader.aspx?Url=/pages/cms/TempDir/books/202306091537-865727e4-cdfb-44cf-920c-ce864fcbcf31//FullPreview&TotalPage=427&ext=jpg#page/1/mode/2up
4. Delévaux I, André M, Colombier M, et al. Can procalcitonin measurement help in differentiating between bacterial infection and other kinds of inflammatory processes? Ann Rheum Dis. 2003;62(4):337-340. doi:10.1136/ard.62.4.337
5. Kucharzik T, Ellul P, Greuter T, et al. ECCO Guidelines on the Prevention, Diagnosis, and Management of Infections in Inflammatory Bowel Disease. J Crohns Colitis. 2021;15(6):879-913. doi:10.1093/ecco-jcc/jjab052
6. Wang R, Li Z, Liu S, Zhang D. Global, regional and national burden of inflammatory bowel disease in 204 countries and territories from 1990 to 2019: a systematic analysis based on the Global Burden of Disease Study 2019. BMJ Open. 2023; 13(3):e065186. doi:10.1136/bmjopen-2022-065186
7. Shah SC, Khalili H, Gower-Rousseau C, et al. Sex-Based Differences in Incidence of Inflammatory Bowel Diseases—Pooled Analysis of Population-Based Studies From Western Countries. Gastroenterology. 2018;155(4):1079-1089.e3. doi:10.1053/j.gastro.2018.06.043
8. Chung SH, Lee HW, Kim SW, et al. Usefulness of Measuring Serum Procalcitonin Levels in Patients with Inflammatory Bowel Disease. Gut Liver. 2016;10(4):574-580. doi:10.5009/gnl15209
9. Risk of bacteremia in hospitalised patients with inflammatory bowel disease: A 9-year cohort study. doi:10.1177/2050640619874524
10. Kirchgesner J, Lemaitre M, Carrat F, Zureik M, Carbonnel F, Dray-Spira R. Risk of Serious and Opportunistic Infections Associated With Treatment of Inflammatory Bowel Diseases. Gastroenterology. 2018;155(2):337-346.e10. doi: 10.1053/j.gastro.2018.04.012